Community/Retail

The risks of undertreating pain in the pediatric population are significant.

Dennis Williams, PharmD, FAPhA, discusses how pharmacists can help implement trigger control strategies to help prevent allergic rhinitis.

Teva Pharmaceutical Industries Ltd has launched a new strength, 1 mg/2 mL, of the generic version of budesonide inhalation suspension.

David Stack, chairman and CEO of Pacira Pharmaceuticals Inc, will be the speaker at Albany College of Pharmacy and Health Sciences' 136th commencement ceremony.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

The American Pharmacists Association released the 2016 edition of the APhA Pharmacists' Patient Care Services Digest.

Jeffrey Goad, PharmD, MPH, FAPhA, discusses vaccine recommendations for special populations including pregnant women and health care professionals.

Between long shifts, pharmacists may not have time to stay on top of the latest legislative and regulatory matters pertinent to their profession.

There has been considerable conversation lately regarding a perceived lack of jobs for pharmacists.

While diabetes is a growing national health threat, it's especially prevalent in Mississippi, where 1 in 8 residents are diabetic.

Sagent Pharmaceuticals Inc is recalling several lots of its atracurium besylate injection due to FDA observations at the manufacturing site that call into question the products' sterility.

Co-host podcaster, Erin L. Albert, MBA, PharmD, JD, interviews returning guest Elaine Voci, PhD, a­ life skills coach and certified life cycle celebrant, about the benefits of professional writing on a pharmacist¹s career.

Jeffrey Goad, PharmD, MPH, FAPhA, discusses vaccine recommendations for immunocompromised patients.

Dennis Williams, PharmD, FAPhA, discusses the signs and symptoms of allergic rhinitis and how pharmacists can differentiate them from those of the common cold.

Few pharmacists opt to protect their income through disability insurance.

The Ohio Northern University Raabe College of Pharmacy will host the fourth annual Ohio Pharmacy Residency Conference.

The life of high-volume retail pharmacists is rarely boring.

CVS Health has announced Be The First, a five-year $50 million initiative to help deliver the nation's first tobacco-free generation.

Sunscreen can do a lot more than prevent painful sunburn.

By mid-April, pharmacists in California should have full authority to distribute hormonal contraception such as the pill, patch, ring, and shot.

Next week brings our nation's greatest teambuilding event: March Madness.

Highly active antiretroviral therapy has dramatically curtailed HIV transmission and AIDS mortality.

Susan Cornell, PharmD, CDE, FAPhA, FAADE forecasts the future landscape for antidiabetic agents recommended as a second-line treatment for type 2 diabetics.

The FDA has approved Janssen Biotech's ibrutinib capsules for treatment-naïve patients with chronic lymphocytic leukemia.

Jon Roth, CEO of the California Pharmacists Association, discusses the protocol for pharmacists when they are dispensing birth control.

Jon Roth, CEO of the California Pharmacists Association, discusses the successes and challenges California pharmacists have faced in dispensing naloxone.

Susan Cornell, PharmD, CDE, FAPhA, FAADE discusses the patient counseling points pharmacists should be aware of for antidiabetic agents.

Susan Cornell, PharmD, CDE, FAPhA, FAADE outlines the classes of antidiabetic agents recommended as a second-line treatment for type 2 diabetics.

Merck has applauded the US Department of Veterans Affairs for broadening access to treatment for Veterans with chronic hepatitis C virus infection.

Jeffrey Goad, PharmD, MPH, FAPhA, discusses some promising new vaccines that are currently in the development pipeline.